{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:44:40Z","timestamp":1791909880266,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003482","name":"Department of Education of Hebei Province","doi-asserted-by":"publisher","award":["CXY2024051"],"award-info":[{"award-number":["CXY2024051"]}],"id":[{"id":"10.13039\/501100003482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2022206201"],"award-info":[{"award-number":["H2022206201"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["226Z2602G"],"award-info":[{"award-number":["226Z2602G"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117381","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:53:31Z","timestamp":1759514011000},"page":"117381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["In Vivo\/In vitro metabolic profiling and evaluation of key metabolites of QO-83, a novel KCNQ channel opener with antiepileptic potential"],"prefix":"10.1016","volume":"242","author":[{"given":"Le","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117381_b0005","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/13543776.2010.513384","article-title":"Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy","volume":"20","author":"Castle","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2025.117381_b0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/ane.13695","article-title":"Potassium channels and epilepsy","volume":"146","author":"Gao","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bcp.2025.117381_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117381_b0020","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117381_b0025","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1113\/jphysiol.2008.154971","article-title":"Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization","volume":"586","author":"Singh","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117381_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-1211(98)00131-4","article-title":"Characterization of the K+ channel opening effect of the anticonvulsant retigabine in PC12 cells","volume":"35","author":"Rundfeldt","year":"1999","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bcp.2025.117381_b0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.108.052282","article-title":"Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels","volume":"75","author":"Lange","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117381_b0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1528-1167.2010.02929.x","article-title":"Remission and relapse in a drug-resistant epilepsy population followed prospectively","volume":"52","author":"Callaghan","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117381_b0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acs.chemrestox.8b00313","article-title":"An investigation into Retigabine (Ezogabine) associated dyspigmentation in rat eyes by MALDI imaging mass spectrometry","volume":"32","author":"Groseclose","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2025.117381_b0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40120-022-00343-x","article-title":"Pharmacokinetics of XEN496, a novel pediatric formulation of Ezogabine, under fed and fasted conditions: a phase 1 trial","volume":"11","author":"Namdari","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.bcp.2025.117381_b0055","doi-asserted-by":"crossref","DOI":"10.1201\/9781003459361","article-title":"A novel compound QO-83 alleviates acute and chronic epileptic seizures in rodents by modulating KV7 channel activity","volume":"31","author":"Wang","year":"2025","journal-title":"CNS Neurosci & Ther."},{"key":"10.1016\/j.bcp.2025.117381_b0060","article-title":"Neuroprotective effects, mechanisms of action and therapeutic potential of the Kv7\/KCNQ channel opener QO-83 in ischemic stroke","author":"Zhang","year":"2025","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.bcp.2025.117381_b0065","unstructured":"Zhang H, Qi J, Jia Q, Du X, Hao H. 4-(p-trifluoromethylbenzyl)-3-fluoro-1,2,4-triphenylamine derivative and pharmaceutical composition and applications thereof. (2020) Patent CN108707087A."},{"key":"10.1016\/j.bcp.2025.117381_b0070","unstructured":"Zhang H, Qi J, Jia Q, Du X, Hao H. 4-(p-trifluoromethylbenzyl)-3-fluoro-1,2,4-triphenylamine derivative and pharmaceutical composition and applications thereof. (2021) Patent US20210269392."},{"key":"10.1016\/j.bcp.2025.117381_b0075","series-title":"Pharmacokinetics of a novel KCNQ channel opener QO-83","author":"Yang","year":"2020"},{"key":"10.1016\/j.bcp.2025.117381_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnmt.117.199588","article-title":"Pharmacology, Part 1: introduction to pharmacology and pharmacodynamics","volume":"46","author":"Currie","year":"2018","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.bcp.2025.117381_b0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000337036","article-title":"Simultaneous determination of a novel diphenylpiperazine calcium channel blocker and its four metabolites in rat liver microsomes by liquid chromatography tandem mass spectrometry","volume":"89","author":"Guo","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2025.117381_b0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/adt.2004.2.525","article-title":"Validation of an atomic absorption rubidium ion efflux assay for KCNQ\/M-channels using the ion Channel Reader 8000","volume":"2","author":"Wang","year":"2004","journal-title":"Assay Drug Dev. Technol."},{"issue":"Suppl 7","key":"10.1016\/j.bcp.2025.117381_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s7.10.x","article-title":"Preclinical development of antiepileptic drugs: past, present, and future directions","volume":"44","author":"White","year":"2003","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2025.117381_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1528-1167.2010.02614.x","article-title":"Effect of neuronal precursor cells derived from medial ganglionic eminence in an acute epileptic seizure model","volume":"51","author":"Calcagnotto","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117381_b0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0090-9556(24)15258-0","article-title":"Metabolism of retigabine (D-23129), a novel anticonvulsant","volume":"27","author":"Hempel","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117381_b0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2885.1983.tb00393.x","article-title":"Acetylation and deacetylation of sulphonamides in dogs","volume":"6","author":"Vree","year":"1983","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117381_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-2952(97)00140-8","article-title":"Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes","volume":"54","author":"Trepanier","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117381_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/carcin\/16.1.71","article-title":"N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs","volume":"16","author":"Okumura","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2025.117381_b0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00008571-199812000-00012","article-title":"Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo","volume":"8","author":"Rothen","year":"1998","journal-title":"Pharmacogenetics"}],"updated-by":[{"DOI":"10.1016\/j.bcp.2026.118543","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500646X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500646X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:15:43Z","timestamp":1778634943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500646X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S000629522500646X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117381","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo\/In vitro metabolic profiling and evaluation of key metabolites of QO-83, a novel KCNQ channel opener with antiepileptic potential","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117381"}}